참고문헌
- Pasqualini, R., Koivunen, E. and Ruoslahti, E. (1997) Alpha v integrins as receptors for tumor targeting by circulating ligands. Nat. Biotechnol., 15, 542-546. https://doi.org/10.1038/nbt0697-542
- Haubner, R., Wester, H.J., Reuning, U., Senekowitsch- Schmidtke, R., Diefenbach, B., Kessler, H., Stocklin, G. and Schwaiger, M. (1999) Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting. J. Nucl. Med., 40, 1061-1071.
- van Hagen, P.M., Breeman, W.A., Bernard, H.F., Schaar, M., Mooij, C.M., Srinivasan, A., Schmidt, M.A., Krenning, E.P. and de Jong, M. (2000) Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy. Int. J. Cancer, 90, 186-198. https://doi.org/10.1002/1097-0215(20000820)90:4<186::AID-IJC2>3.0.CO;2-P
-
Haubner, R., Bruchertseifer, F., Bock, M., Kessler, H., Schwaiger, M. and Wester, H.J. (2004) Synthesis and biological evaluation of a
$^{99m}Tc$ -labelled cyclic RGD peptide for imaging the alphavbeta3 expression. Nuklearmedizin, 43, 26-32. - Harris, T.D., Kalogeropoulos, S., Nguyen, T., Liu, S., Bartis, J., Ellars, C., Edwards, S., Onthank, D., Silva, P., Yalamanchili, P., Robinson, S., Lazewatsky, J., Barrett, J. and Bozarth, J. (2003) Design, synthesis, and evaluation of radiolabeled integrin alpha v beta 3 receptor antagonists for tumor imaging and radiotherapy. Cancer Biother. Radiopharm., 18, 627-641. https://doi.org/10.1089/108497803322287727
-
Chen, X., Park, R., Tohme, M., Shahinian, A.H., Bading, J.R. and Conti, P.S. (2004) MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using
$^{18}F$ - and$^{64}Cu$ -labeled RGD peptide. Bioconjugate Chem., 15, 41-49. https://doi.org/10.1021/bc0300403 -
Onthank, D.C., Liu, S., Silva, P.J., Barrett, J.A., Harris, T.D., Robinson, S.P. and Edwards, D.S. (2004)
$^{90}Y$ and$^{111}In$ complexes of a DOTA-conjugated integrin alpha v beta 3 receptor antagonist: different but biologically equivalent. Bioconjugate Chem., 15, 235-241. https://doi.org/10.1021/bc034108q -
Li, L., Wartchow, C.A., Danthi, S.N., Shen, Z., Dechene, N., Pease, J., Choi, H.S., Doede, T., Chu, P., Ning, S., Lee, D.Y., Bednarski, M.D. and Knox, S.J. (2004) A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated
$^{90}Y$ -labeled nanoparticles. Int. J. Radiat. Oncol. Biol. Phys., 58, 1215-1227. https://doi.org/10.1016/j.ijrobp.2003.10.057 - Haubner, R., Wester, H.J., Burkhart, F., Senekowitsch- Schmidtke, R., Weber, W., Goodman, S.L., Kessler, H. and Schwaiger, M. (2001) Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J. Nucl. Med., 42, 326-336.
- Chen, X., Park, R., Shahinian, A.H., Bading, J.R. and Conti, P.S. (2004) Pharmacokinetics and tumor retention of 125Ilabeled RGD peptide are improved by PEGylation. Nucl. Med. Biol., 31, 11-19. https://doi.org/10.1016/j.nucmedbio.2003.07.003
-
Chen, X., Park, R., Hou, Y., Khankaldyyan, V., Gonzales- Gomez, I., Tohme, M., Bading, J.R., Laug, W.E. and Conti, P.S. (2004) MicroPET imaging of brain tumor angiogenesis with
$^{18}F$ -labeled PEGylated RGD peptide. Eur. J. Nucl. Med. Mol. Imaging, 31, 1081-1089. -
Chen, X., Hou, Y., Tohme, M., Park, R., Khankaldyyan, V., Gonzales-Gomez, I., Bading, J.R., Laug, W.E. and Conti, P.S. (2004) Pegylated Arg-Gly-Asp peptide:
$^{64}Cu$ labeling and PET imaging of brain tumor alphavbeta3-integrin expression. J. Nucl. Med., 45, 1776-1783. - Hood, J.D., Bednarski, M., Frausto, R., Guccione, S., Reisfeld, R.A., Xiang, R. and Cheresh, D.A. (2002) Tumor regression by targeted gene delivery to the neovasculature. Sci., 296, 2404-2407. https://doi.org/10.1126/science.1070200
- Burnett, C.A., Xie, J., Quijano, J., Shen, Z., Hunter, F., Bur, M., Li, K.C. and Danthi, S.N. (2005) Synthesis, in vitro, and in vivo characterization of an integrin alpha(v)beta(3)-targeted molecular probe for optical imaging of tumor. Bioorg. Med. Chem., 13, 3763-3771. https://doi.org/10.1016/j.bmc.2005.03.024
- Waibel, R., Alberto, R., Willuda, J., Finnern, R., Schibli, R., Stichelberger, A., Egli, A., Abram, U., Mach, J.P., Plückthun, A. and Schubiger, P.A. (1999) Stable one-step technetium- 99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex. Nat. Biotechnol., 17, 897-901. https://doi.org/10.1038/12890
-
Schibli, R., Katti, K.V., Higginbotham, C., Volkert, W.A. and Alberto, R. (1999) In vitro and in vivo evaluation of bidentate, water-soluble phosphine ligands as anchor groups for the organometallic
$fac-[^{99m}Tc(CO)_{3}]^{+}$ -core. Nucl. Med. Biol., 26, 711-716. https://doi.org/10.1016/S0969-8051(99)00028-1 -
Schibli, R., La Bella, R., Alberto, R., Garcia-Garayoa, E., Ortner, K., Abram, U. and Schubiger, P.A. (2000) Influence of the denticity of ligand systems on the in vitro and in vivo behavior of
$^{99m}Tc(I)$ -tricarbonyl complexes: a hint for the future functionalization of biomolecules. Bioconjugate Chem., 11, 345-351. https://doi.org/10.1021/bc990127h -
Pietzsch, H.J., Gupta, A., Reisgys, M., Drews, A., Seifert, S., Syhre, R., Spies, H., Alberto, R., Abram, U., Schubiger, P.A. and Johannsen, B. (2000) Chemical and biological characterization of technetium(I) and Rhenium(I) tricarbonyl complexes with dithioether ligands serving as linkers for coupling the
$Tc(CO)_{3}$ and$Re(CO)_{3}$ moieties to biologically active molecules. Bioconjugate Chem., 11, 414-424. https://doi.org/10.1021/bc990162o - Bullok, K.E., Dyszlewski, M., Prior, J.L., Pica, C.M., Sharma, V. and Piwnica-Worms, D. (2002) Characterization of novel histidine-tagged Tat-peptide complexes dual-labeled with (99m)Tc-tricarbonyl and fluorescein for scintigraphy and fluorescence microscopy. Bioconjugate Chem., 13, 1226-1237. https://doi.org/10.1021/bc025573a
-
Smith, C.J., Sieckman, G.L., Owen, N.K., Hayes, D.L., Mazuru, D.G., Kannan, R., Volkert, W.A. and Hoffman, T.J. (2003) Radiochemical investigations of gastrin-releasing peptide receptor-specific [
$^{99m}Tc(X)(CO)_{3}$ -Dpr-Ser-Ser-Ser-Gln- Trp-Ala-Val-Gly-His-Leu-Met-($NH_{2}$ )] in PC-3, tumor-bearing, rodent models: syntheses, radiolabeling, and in vitro/in vivo studies where Dpr = 2,3-diaminopropionic acid and X =$H_{2}O$ or$P(CH_{2}OH)_{3}$ . Cancer Res., 63, 4082-4088. -
Salignac, B., Grundler, P.V., Cayemittes, S., Frey, U., Scopelliti, R., Merbach, A.E., Hedinger, R., Hegetschweiler, K., Alberto, R., Prinz, U., Raabe, G., Kolle, U. and Hall, S. (2003) Reactivity of the organometallic
$fac-[(CO)_{3}ReI(H_{2}O)_{3}]^{+}$ aquaion. Kinetic and thermodynamic properties of$H_{2}O$ substitution. Inorg. Chem., 42, 3516-3526. https://doi.org/10.1021/ic0341744 -
Trump, D.P., Mathias, C.J., Yang, Z., Low, P.S., Marmion, M. and Green, M.A. (2002) Synthesis and evaluation of
$^{99m}Tc(CO)_{3}$ - DTPA-folate as a folate-receptor-targeted radiopharmaceutical. Nucl. Med. Biol., 29, 569-573. https://doi.org/10.1016/S0969-8051(02)00310-4 - Schibli, R. and Schubiger, P.A. (2002) Current use and future potential of organometallic radiopharmaceuticals. Eur. J. Nucl. Med. Mol. Imaging, 29, 1529-1542. https://doi.org/10.1007/s00259-002-0900-8